Boule Diagnostics Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Public

  • Employees
  • 178

Employees

  • Stock Symbol
  • BOUL

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $0.13
  • (As of Monday Closing)

Boule Diagnostics General Information

Description

Boule Diagnostics AB is a company operating in the diagnostics market. It is engaged in the development, manufacturing and marketing instruments and consumables for blood diagnostics. The systems are intended for small and medium-sized hospitals, clinics and laboratories within outpatient care. the company operating through two complementary business segments: Diagnostics and OEM CDS. Through its subsidiaries, the company operates in USA ,Asia, Eastern Europe, Latin America Western Europe and Africa / Middle East. The majority revenue is generated from Asia.

Contact Information

Website
www.boule.com
Formerly Known As
Karo Bio Diagnostics
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Fagerstagatan 7
  • 163 53 Spanga
  • Sweden
+46 08-744
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Electronic Equipment and Instruments
Stock Exchange
STO
Corporate Office
  • Fagerstagatan 7
  • 163 53 Spanga
  • Sweden
+46 08-744

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Boule Diagnostics Stock Performance

As of 16-Nov-2026, Boule Diagnostics’s stock price is $0.13. Its current market cap is $4.91M with 38.8M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.13 $0.12 $0.09 - $0.66 $4.91M 38.8M 313K -$0.05

Boule Diagnostics Financials Summary

As of 30-Sep-2026, Boule Diagnostics has a trailing 12-month revenue of $45.8M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 29,791 40,875 46,321 57,085
Revenue 45,783 49,843 52,805 53,751
EBITDA 458 4,358 (30,746) 6,368
Net Income (1,841) (382) (28,043) 2,350
Total Assets 46,368 51,028 46,849 75,556
Total Debt 21,658 24,316 17,679 16,627
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Boule Diagnostics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Boule Diagnostics‘s full profile, request access.

Request a free trial

Boule Diagnostics Patents

Boule Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2020501114-A Method and device for counting platelets in capillary blood Active 11-Nov-2016
ES-2874180-T3 Method and device for counting thrombocytes in capillary blood Active 11-Nov-2016
EP-3538887-A1 Method and device for thrombocyte counting in capillary blood Active 11-Nov-2016
EP-3538887-B1 Method and device for thrombocyte counting in capillary blood Active 11-Nov-2016
US-20200096530-A1 Method and device for thrombocyte counting in capillary blood Inactive 11-Nov-2016 G01N35/1095
To view Boule Diagnostics’s complete patent history, request access »

Boule Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Boule Diagnostics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Boule Diagnostics‘s full profile, request access.

Request a free trial

Boule Diagnostics Investments & Acquisitions (2)

Boule Diagnostics’s most recent deal was a Later Stage VC with Biosurfit for . The deal was made on 14-Dec-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Biosurfit 14-Dec-2018 Later Stage VC Diagnostic Equipment
Drew Scientific (2280 hematology platform and laser module product line) 18-Apr-2018 Merger/Acquisition Laboratory Services (Healthcare)
To view Boule Diagnostics’s complete investments and acquisitions history, request access »

Boule Diagnostics ESG

Risk Overview

Risk Rating

Updated September, 30, 2025

30.03 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,999

Rank

Percentile

Healthcare

Industry

of 665

Rank

Percentile

Medical Devices

Subindustry

of 235

Rank

Percentile

To view Boule Diagnostics’s complete esg history, request access »

Boule Diagnostics Exits (1)

Boule Diagnostics’s most recent exit was on 14-Dec-2018 from Biosurfit. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Biosurfit 14-Dec-2018 Completed
  • 2 buyers
To view Boule Diagnostics’s complete exits history, request access »

Boule Diagnostics Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Boule Medical Spaanga, Sweden 1969

Boule Diagnostics FAQs

  • When was Boule Diagnostics founded?

    Boule Diagnostics was founded in 1992.

  • Where is Boule Diagnostics headquartered?

    Boule Diagnostics is headquartered in Spanga, Sweden.

  • What is the size of Boule Diagnostics?

    Boule Diagnostics has 178 total employees.

  • What industry is Boule Diagnostics in?

    Boule Diagnostics’s primary industry is Diagnostic Equipment.

  • Is Boule Diagnostics a private or public company?

    Boule Diagnostics is a Public company.

  • What is Boule Diagnostics’s stock symbol?

    The ticker symbol for Boule Diagnostics is BOUL.

  • What is the current stock price of Boule Diagnostics?

    As of 16-Nov-2026 the stock price of Boule Diagnostics is $0.13.

  • What is the current market cap of Boule Diagnostics?

    The current market capitalization of Boule Diagnostics is $4.91M.

  • What is Boule Diagnostics’s current revenue?

    The trailing twelve month revenue for Boule Diagnostics is $45.8M.

  • What is Boule Diagnostics’s annual earnings per share (EPS)?

    Boule Diagnostics’s EPS for 12 months was -$0.05.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process